Schering Vanceril phase-out
Executive Summary
Schering-Plough completely discontinues Vanceril with phase-out of 42 mcg strength, company says. Vanceril (beclomethasone) 84 mcg was previously discontinued as part of Schering's consent decree with FDA (1"The Pink Sheet" May 27, p. 13). The lower strength of the asthma drug had been on back-order for some time, Schering said. Vanceril generated $82 mil. in sales in 2001...
You may also be interested in...
Qvar Sales Reps Grow To 200; Ivax Sees Outlicensing Opportunities From R&D
Ivax will have 200 sales reps to promote Qvar and its other respiratory products by the end of the year, President Neil Flanzraich said in Ivax's third quarter conference call Oct. 29
Schering Rebetol Is Only “Medically Necessary” Oral Product In FDA Decree
Schering-Plough's Rebetol (ribavirin capsules) is the only oral product deemed "medically necessary" under the company's consent decree with FDA
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.